Public Release:  Europe's major psychiatry congress -- Berlin, October 2014

Europe's most important psychiatry conference, the 27th European Congress of Neuropsychopharmacology -- ECNP -- will take place in Berlin from 18 to 21 Oct., 2014

European College of Neuropsychopharmacology

Europe's most important psychiatry conference, the 27th European Congress of Neuropsychopharmacology (ECNP) will take place in Berlin from 18 to 21 October, 2014.

Neuropsychopharmacology includes many fields which attract significant press attention, such as depression, addiction, Alzheimer's disease, ADHD, etc. Up to 7000 delegates are expected to attend the Berlin congress. The 2014 congress will have a particularly interesting programme, including sessions on:

  • Personalised treatment of major depression
  • New European pharma research initiatives
  • Neuropeptides, obesity and addiction
  • Neurobiology of ADHD across the lifespan

Journalists are welcome to attend the conference, and can register at: http://www.ecnp-congress.eu/registrationhotel/press-registration.aspx

Journalists who cannot attend can still receive advance press releases, by contacting press@ecnp.eu

The congress website is: http://www.ecnp-congress.eu/sitecore/content/Congress2014/ECNP%20Congress.aspx?sc_lang=en

The ECNP is Europe largest and most important psychiatric organisation. The ECNP is committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health. Website: http://www.ecnp.eu/

###

For more information about the congress, or for general information on the ECNP and its activities, please contact the ECNP Press Officer, Tom Parkhill:

Email: press@ecnp.eu
tel: +39 349 238 8191

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.